514336 GENESIS

Genesis IBRC India Share Price

 

 

Start SIP in GENESIS

Start SIP

Performance

  • Low
  • ₹82
  • High
  • ₹82
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹185
  • Open Price₹82
  • Previous Close₹86
  • Volume89
  • 50 DMA₹101.26
  • 100 DMA₹92.24
  • 200 DMA₹68.81

Investment Returns

  • Over 1 Month -9.87%
  • Over 3 Month -22.78%
  • Over 6 Month + 249.29%
  • Over 1 Year + 367.66%

Smart Investing Starts Here Start SIP with Genesis IBRC India for Steady Growth!

Invest Now

Genesis IBRC India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -459
  • PEG Ratio
  • 10.3
  • Market Cap Cr
  • 106
  • P/B Ratio
  • 12.7
  • Average True Range
  • 5.32
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -8.98
  • RSI
  • 32.6
  • MFI
  • 25.06

Genesis IBRC India Financials

Genesis IBRC India Technicals

EMA & SMA

Current Price
₹81.70
-4.3 (-5%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹90.88
  • 50 Day
  • ₹101.26
  • 100 Day
  • ₹92.24
  • 200 Day
  • ₹68.81

Resistance and Support

81.7 Pivot Speed
  • R3 81.70
  • R2 81.70
  • R1 81.70
  • S1 81.70
  • S2 81.70
  • S3 81.70

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Genesis Ibrc India has an operating revenue of Rs. 4.38 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of 41% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 59% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genesis IBRC India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-29 Audited Results
2025-02-14 Quarterly Results
2024-11-14 Quarterly Results

Genesis IBRC India F&O

Genesis IBRC India Shareholding Pattern

11.33%
32.01%
56.66%

Genesis IBRC India FAQs

Genesis IBRC India share price is ₹81 As on 15 January, 2026 | 09:47

The Market Cap of Genesis IBRC India is ₹106.2 Cr As on 15 January, 2026 | 09:47

The P/E ratio of Genesis IBRC India is -459 As on 15 January, 2026 | 09:47

The PB ratio of Genesis IBRC India is 12.7 As on 15 January, 2026 | 09:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23